Ignite Creation Date:
2024-05-06 @ 10:15 AM
Last Modification Date:
2024-10-26 @ 12:27 PM
Study NCT ID:
NCT03201094
Status:
RECRUITING
Last Update Posted:
2024-05-31
First Post:
2017-06-23
Brief Title:
Impact of NMES and HPRO on Recovery After SAH- Pilot Study
Sponsor:
University of Maryland Baltimore
Organization:
University of Maryland Baltimore
Study Overview
Official Title:
Impact of Neuromuscular Stimulation and High Protein Nutritional Supplementation on Long-term Recovery After Aneurysmal Subarachnoid Hemorrhage
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study purpose is to investigate the hypothesis that in adults with SAH early neuromuscular electrical stimulation NMES and high protein supplementation HPRO will improve muscle mass metabolic and inflammatory biomarker profiles compared to SAH controls receiving standard of care interventions for nutrition and mobilization The investigators will accomplish this by studying the effects of a high protein HPRO nutritional treatment as well as NMES intervention have upon muscle wasting and motor strength acutely after SAH This will be addressed in a prospective trial of SAH patients receiving HRPO with NMES as compared to age and severity-matched SAH patients undergoing standard of care interventions for nutrition and mobilization Additionally the study will investigate the impact HPRO and NMES interventions have upon inflammatory cytokines and markers of energy balance Results of this study will establish evidence for precision nutrition plus early exercise to mitigate the catabolic and inflammatory state produced by SAH to improve muscle metabolic and health recovery outcomes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None